Gain Therapeutics (GANX) - Market Cap to Earnings

Corporate emblem and logo of Gain Therapeutics Inc. (GANX)

Gain Therapeutics, Inc. (GANX) automates the discovery of treatments for neurodegenerative pathologies using AI platforms and robotic molecule screening. A lack of commercial sales and reliance on external funding render cash flows unpredictable. This price action reflects a market valuation of -2.30. Current growth is supported by grants for Parkinson's disease research, while the anticipation of early-phase trial results will serve as a future catalyst.

Gain Therapeutics Inc. - GANX Price to Earnings Ratio (period 07/04/2022 - 11/17/2026)

Comprehensive metric breakdowns and analytics for gaintherapeutics.com (GANX)

Summary company analysis:Gain Therapeutics, Inc.
Mass-produced product of Gain Therapeutics, Inc.

For Gain Therapeutics, Inc. (GANX), which is developing unique methods to combat Parkinson's disease by targeting proteins, the business valuation relative to its yield becomes a critical efficiency filter. By analyzing the company's adjusted P/E, an investor compares market capitalization with net income, allowing for a determination of the asset's overvaluation and an assessment of whether investments in high-risk medical developments are justified.

Analysis of competing companies

Market Cap to Earnings hcahealthcare.com HCA|Price to Earnings Ratio Tenet Healthcare (THC)|Fresenius Medical Care - Price to Earnings Multiple|Price to Earnings Ratio Solventum SOLV|Market Price to Net Income Ratio EHC (Encompass Health)|UHS: Price to Earnings Ratio|DVA (DaVita) - Price to Earnings Multiple|RadNet Corp (RDNT) - Price to Earnings Ratio|Market Cap to Earnings Option Care Corp (OPCH)|Price to Earnings Ratio SGRY|PINC: Company Value to Net Income|P/E Multiple EYE|PGNY - Market Cap to Earnings|P/E Multiple ARDT (ardenthealth.com)|SEM - Price to Earnings Ratio|Astrana Corp - P/E Multiple|Company Value to Net Income MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Price to Earnings Ratio|Market Cap to Earnings Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - P/E Multiple|NUTX: Company Value to Net Income|P/E Multiple AUNA|Price to Earnings Ratio SBC Medical Group Holdings Inc SBC|Price to Earnings Ratio Jeuveau EOLS|Company Value to Net Income CYH|SKIN: Price to Earnings Ratio|Company Value to Net Income MDWD (MediWound)|BTMD (biote.com) - Price to Earnings Ratio|Price to Earnings Ratio thejoint.com|DCGO (DocGo, Inc.) - P/E Multiple|Price to Earnings Ratio PIII|Price to Earnings Ratio EUDA (EUDA Health Holdings)|Price to Earnings Ratio BMGL (Basel Medical Group Limited)|CollPlant Biotechnologies Ltd. - Price to Earnings Ratio|CUPR: Price to Earnings Multiple|CCM: Price to Earnings Ratio|Company Value to Net Income AMS (American Shared Hospital Services)|MRM: P/E Multiple|Market Cap to Earnings Avalon GloboCare Corp (ALBT)|Price to Earnings Ratio DIH Holding|XAGE: Company Value to Net Income|P/E Multiple NIVF|P/E Multiple ATI Physical Therapy Inc. (ATIP)|P/E Multiple CMAX (caremax.com)|Market Price to Net Income Ratio KDLY (Kindly Health)|MODV - Price to Earnings Ratio|Market Cap to Earnings novointegrated.com|SunLink Health Systems (SSY) - Price to Earnings Ratio|Price to Earnings Ratio IMAC Holdings Inc